Beneficial effects of plasmapheresis followed by immunosuppressive therapy in pretibial myxedema.
Noppen
M
M
Velkeniers
B
B
Steenssens
L
L
Vanhaelst
L
L
D001379:Azathioprine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D007868:Leg Dermatoses / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000628:therapy*; D010956:Plasmapheresis
D005446:Fluocinolone Acetonide; D001379:Azathioprine